Works matching IS 02704137 AND DT 2017 AND VI 77 AND IP 15

Results: 10

Impact of five-tiered Gleason grade groups on prognostic prediction in clinical stage T3 prostate cancer undergoing high-dose-rate brachytherapy.

Published in:

Prostate, 2017, v. 77, n. 15, p. 1520, doi. 10.1002/pros.23430

By:

Tsumura, Hideyasu;
Ishiyama, Hiromichi;
Tabata, Ken‐ichi;
Katsumata, Hiroki;
Kobayashi, Momoko;
Ikeda, Masaomi;
Kurosaka, Shinji;
Fujita, Tetsuo;
Kitano, Masashi;
Satoh, Takefumi;
Yanagisawa, Nobuyuki;
Hayakawa, Kazushige;
Iwamura, Masatsugu

Publication type:

Article

The unidirectional hypoxia-activated prodrug OCT1002 inhibits growth and vascular development in castrate-resistant prostate tumors.

Published in:

Prostate, 2017, v. 77, n. 15, p. 1539, doi. 10.1002/pros.23434

By:

Nesbitt, Heather;
Worthington, Jenny;
Errington, Rachel J.;
Patterson, Laurence H.;
Smith, Paul J.;
McKeown, Stephanie R.;
McKenna, Declan J.

Publication type:

Article

High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer.

Published in:

Prostate, 2017, v. 77, n. 15, p. 1528, doi. 10.1002/pros.23431

By:

Burdelski, Christoph;
Shihada, Rami;
Hinsch, Andrea;
Angerer, Alexander;
Göbel, Cosima;
Friedrich, Emily;
Hube‐Magg, Claudia;
Burdak‐Rothkamm, Susanne;
Kluth, Martina;
Simon, Ronald;
Möller‐Koop, Christina;
Sauter, Guido;
Büscheck, Franzika;
Wittmer, Corinna;
Clauditz, Till S.;
Krech, Till;
Tsourlakis, Maria C.;
Minner, Sarah;
Graefen, Markus;
Schlomm, Thorsten

Publication type:

Article

The protein kinase C super-family member PKN is regulated by mTOR and influences differentiation during prostate cancer progression.

Published in:

Prostate, 2017, v. 77, n. 15, p. 1452, doi. 10.1002/pros.23400

By:

Yang, Chun‐Song;
Melhuish, Tiffany A.;
Spencer, Adam;
Ni, Li;
Hao, Yi;
Jividen, Kasey;
Harris, Thurl E.;
Snow, Chelsi;
Frierson, Henry F.;
Wotton, David;
Paschal, Bryce M.

Publication type:

Article

Issue Information - Editorial Board.

Published in:: Prostate, 2017, v. 77, n. 15, p. 1451, doi. 10.1002/pros.23337
Publication type:: Article

Reduced number of CD169<sup>+</sup> macrophages in pre-metastatic regional lymph nodes is associated with subsequent metastatic disease in an animal model and with poor outcome in prostate cancer patients.

Published in:

Prostate, 2017, v. 77, n. 15, p. 1468, doi. 10.1002/pros.23407

By:

Strömvall, Kerstin;
Sundkvist, Kristoffer;
Ljungberg, Börje;
Halin Bergström, Sofia;
Bergh, Anders

Publication type:

Article

Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy Meeting.

Published in:

Prostate, 2017, v. 77, n. 15, p. 1478, doi. 10.1002/pros.23424

By:

Miyahira, Andrea K.;
Cheng, Heather H.;
Abida, Wassim;
Ellis, Leigh;
Harshman, Lauren C.;
Spratt, Daniel E.;
Simons, Jonathan W.;
Pienta, Kenneth J.;
Soule, Howard R.

Publication type:

Article

Hyperactive mTOR induces neuroendocrine differentiation in prostate cancer cell with concurrent up-regulation of IRF1.

Published in:

Prostate, 2017, v. 77, n. 15, p. 1489, doi. 10.1002/pros.23425

By:

Kanayama, Mayuko;
Hayano, Toshiya;
Koebis, Michinori;
Maeda, Tatsuya;
Tabe, Yoko;
Horie, Shigeo;
Aiba, Atsu

Publication type:

Article

Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer.

Published in:

Prostate, 2017, v. 77, n. 15, p. 1499, doi. 10.1002/pros.23426

By:

Pedraza‐Arévalo, Sergio;
Hormaechea‐Agulla, Daniel;
Gómez‐Gómez, Enrique;
Requena, María J.;
Selth, Luke A.;
Gahete, Manuel D.;
Castaño, Justo P.;
Luque, Raul M.

Publication type:

Article

Sexual steroids in serum and prostatic tissue of human non-cancerous prostate (STERPROSER trial).

Published in:

Prostate, 2017, v. 77, n. 15, p. 1512, doi. 10.1002/pros.23429

By:

Neuzillet, Yann;
Raynaud, Jean‐Pierre;
Radulescu, Camélia;
Fiet, Jean;
Giton, Franck;
Dreyfus, Jean‐François;
Ghoneim, Tarek P.;
Lebret, Thierry;
Botto, Henry

Publication type:

Article